The Market Reports

Synopsis
The global market for Tetrahydrocurcumin was estimated to be worth US$ 7.6 million in 2024 and is forecast to a readjusted size of US$ 10.5 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Tetrahydrocurcumin (CAS 36062-04-1) is a natural compound derived from curcumin, the main active ingredient found in turmeric. Curcumin is well-known for its bright yellow color, while tetrahydrocurcumin has a lighter and more pale yellow or off-white color compared to curcumin. Tetrahydrocurcumin is an antioxidant and skin-whitening ingredient. It can effectively inhibit the generation of tyrosinase and oxygen free radicals and clear the formed free radicals, which has obvious antioxidant effect, and has been used as natural functional whitening raw materials in the research and development of cosmetics. Tetrahydrocurcumin is also a major curcuminoid metabolite of curcumin that has been shown to have protective effects against diabetes and vascular dysfunction via alleviation of oxidative stress. Also, many in vitro and in vivo studies have revealed that tetrahydrocurcumin exerts anti-cancer effects through various mechanisms, including modulation of oxidative stress, xenobiotic detoxification, inflammation, proliferation, metastasis, programmed cell death, and immunity.
Global key players of Tetrahydrocurcumin include Huateng Pharma, Hangzhou Great Forest, Hangzhou Lingeba Technology, etc. The top three players hold a share over 35%. Asia-Pacific is the largest market, and has a share about 48%, followed by Europe and North America with share 23% and 22%, separately. In terms of product type, ≥98% is the largest segment, occupied for a share of 69%. In terms of application, Cosmetics has a share about 75 percent.
This report aims to provide a comprehensive presentation of the global market for Tetrahydrocurcumin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Tetrahydrocurcumin by region & country, by Type, and by Application.
The Tetrahydrocurcumin market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tetrahydrocurcumin.
Market Segmentation
By Company
Huateng Pharma
Hangzhou Great Forest
Hangzhou Lingeba Technology
Hangzhou Linran Biotechnology
Plamed Green Science
Sinoway Industrial
Segment by Type
≥98%
<98%
Segment by Application
Cosmetics
Pharmaceutical
Food
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Tetrahydrocurcumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Tetrahydrocurcumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Tetrahydrocurcumin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index